Definition of the transcription factors which bind the differentiation responsive element of the Epstein-Barr virus BZLF1 Z promoter in human epithelial cells

References

1. Benbrook D. M., Jones N. C. 1990; Heterodimer formation between CREB and JUN proteins. Oncogene 5:295–302
   [Google Scholar]
2. Bowlus C. L., McQuillan J. J., Dean D. C. 1991; Characterization of three different elements in the 5′-flanking region of the fibronectin gene which mediate a transcriptional response to cAMP. Journal of Biological Chemistry 266:1122–1127
   [Google Scholar]
3. Chatila T., Ho N., Liu P., Liu S., Mosialos G., Kieff E., Speck S. H. 1997; The Epstein–Barr virus-induced Ca²⁺/calmodulin-dependent kinase typelV/Gr promotes a Ca²⁺-dependent switch from latency to viral replication. Journal of Virology 71:6560–6567
   [Google Scholar]
4. Chevallier-Greco A., Manet E., Chavrier P., Mosnier C., Daillie J., Sergeant A. 1986; Both Epstein–Barr virus (EBV)-encoded transacting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO Journal 5:3243–3249
   [Google Scholar]
5. Countryman J., Miller G. 1985; Activation of expression of latent Epstein–Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proceedings of the National Academy of Sciences, USA 82:4085–4089
   [Google Scholar]
6. Crawford D. H., Ando I. 1986; EB virus induction is associated with B cell maturation. Immunology 59:405–409
   [Google Scholar]
7. Daibata M., Speck S. H., Mulder C., Sairenji T. 1994; Regulation of the BZLF1 promoter of Epstein–Barr virus by second messengers in anti-immunoglobulin-treated B cells. Virology 198:446–454
   [Google Scholar]
8. Dean D. C., Blakeley M. S., Newby R. F., Ghazal P., Hennighausen L., Bourgeois S. 1989; Forskolin inducibility and tissue-specific expression of the fibronectin promoter. Molecular and Cellular Biology 9:1498–1506
   [Google Scholar]
9. Dignam J. D., Lebovitz R. M., Roeder R. G. 1983; Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Research 11:1475–1489
   [Google Scholar]
10. Dover R., Watt F. M. 1987; Measurement of the rate of epidermal terminal differentiation: expression of involucrin by S-phase keratino-cytes in culture and in psoriatic plaques. Journal of Investigative Dermatology 89:349–352
    [Google Scholar]
11. Ellis M. J. C., Lindon A. C., Flint K. J., Jones N. C., Goodbourn S. 1995; Activating transcription factor-1 is a specific antagonist of the cyclic adenosine 3′, 5′-monophosphate (cAMP) response element-binding protein-1-mediated response to cAMP. Molecular Endocrinology 9:255–265
    [Google Scholar]
12. Flamand L., Menezes J. 1996; Cyclic AMP-responsive element-dependent activation of Epstein–Barr virus zebra promoter by human herpesvirus 6. Journal of Virology 70:1784–1791
    [Google Scholar]
13. Flemington E., Speck S. H. 1990a; Identification of phorbol ester response elements in the promoter of Epstein–Barr virus putative lytic switch gene BZLF1. Journal of Virology 64:1217–1226
    [Google Scholar]
14. Flemington E., Speck S. H. 1990b; Autoregulation of Epstein–Barr virus putative lytic switchgene BZLF1. JournalofVirology 64:1227–1232
    [Google Scholar]
15. Gandarillas A., Watt F. M. 1995; Changes in expression of the fos and jun families and myc network during terminal differentiation of human keratinocytes. Oncogene 11:1403–1407
    [Google Scholar]
16. Golden H. D., Chang R. S., Prescott W., Simpson E., Cooper T. Y. 1973; Leukocyte-transforming agent: prolonged excretion by patients with mononucleosis and excretion by normal individuals. Journal of Infectious Diseases 127:471–473
    [Google Scholar]
17. Gonzalez G. A., Montminy M. R. 1989; Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59:675–680
    [Google Scholar]
18. Green H. 1977; Terminal differentiation of cultured human epidermal cells. Cell 11:405–416
    [Google Scholar]
19. Henle G., Henle W., Diehl V. 1968; Relation of Burkitt s tumor-associated herpes-type virus to infectious mononucleosis. Proceedings of the National Academy of Sciences, USA 59:94–101
    [Google Scholar]
20. Hsueh Y.-P., Lai M.-Z. 1995; Overexpression of activation transcriptional factor 1 in lymphomas and in activated lymphocytes. Journal of Immunology 154:5675–5683
    [Google Scholar]
21. Israele V., Shirley P., Sixbey J. W. 1991; Excretion of the Epstein–Barr virus from the genital tract of men. Journal of Infectious Diseases 163:1341–1343
    [Google Scholar]
22. Karimi L., Crawford D. H., Speck S., Nicholson L. J. 1995; Identification of an epithelial cell differentiation responsive region within the BZLF1 promoter of the Epstein–Barr virus. Journal of General Virology 76:759–765
    [Google Scholar]
23. Kieff E. 1996; Epstein–Barr virus and its replication. In Fields Virology 3rd edn, pp 2343–2396 Edited by Fields B., Knipe D., Howley P. Philadelphia: Lippincott–Raven;
    [Google Scholar]
24. Laux G., Freese U. K., Fischer R., Polack A., Kofler E., Bornkamm G. W. 1988; TPA-inducible Epstein–Barr virus genes in Raji cells and their regulation. Virology 162:503–507
    [Google Scholar]
25. Lee C. Q., Yun Y., Hoeffler J. P., Habener J. F. 1990; Cyclic-AMP-responsive transcriptional activation of CREB-327 involves interdependent phosphorylated subdomains. EMBO Journal 9:4455–4465
    [Google Scholar]
26. Li Q. X., Young L. S., Niedobitek G., Dawson C. W., Birkenbach M., Wang F., Rickinson A. B. 1992; Epstein–Barr virus infection and replication in a human epithelial cell system. Nature 356:347–350
    [Google Scholar]
27. Liu F., Thompson M. A., Wagner S., Greenberg M. E., Green M. R. 1993; Activating transcription factor-1 can mediate Ca²⁺- and cAMP-inducible transcriptional activation. Journal of Biological Chemistry 268:6714–6720
    [Google Scholar]
28. Liu S., Borras A. M., Liu P., Suske G., Speck S. H. 1997a; Binding of the ubiquitous cellular transcription factors Sp1 and Sp3 to the ZI domains in the Epstein–Barr virus lytic switch BZLF1 gene promoter. Virology 228:11–18
    [Google Scholar]
29. Liu S., Liu P., Borras A., Chatila T., Speck S. H. 1997b; Cyclosporin A-sensitive induction of the Epstein–Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member. EMBO Journal 16:143–153
    [Google Scholar]
30. Luka J., Kallin B., Klein G. 1979; Induction of the Epstein–Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94:228–231
    [Google Scholar]
31. Manet E., Gruffat H., Trescol-Biemont M. C., Moreno I., Chambard P., Giot J. F., Sergeant A. 1989; Epstein –Barr virus bicistronic mRNA’s generated by facultative splicing code for two transcriptional trans-activators. EMBO Journal 8:1819–1826
    [Google Scholar]
32. Meyer T. E., Habener J. F. 1993; Cyclic adenosine 3, 5-mono-phosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid-binding proteins. Endocrine Reviews 14:269–290
    [Google Scholar]
33. Miyashita E. M., Yang B., Lam K. M. C., Crawford D. H., Thorley-Lawson D. A. 1995; A novel form of Epstein–Barr virus latency in normal B cells in vivo. Cell 80:593–601
    [Google Scholar]
34. Montalvo E. A., Shi Y., Shenk T. E., Levine A. J. 1991; Negative regulation of the BZLF1 promoter of Epstein–Barr virus. Journal of Virology 65:3647–3655
    [Google Scholar]
35. Montalvo E. A., Cottam M., Hill S., Wang Y.-C. J. 1995; YY1 binds to and regulates cis-acting negative elements in the Epstein–Barr virus BZLF1 promoter. Journal of Virology 69:4158–4165
    [Google Scholar]
36. Nicholson L. J., Watt F. M. 1991; Decreased expression of fibronectin and the α₅β₁ integrin during terminal differentiation of human keratinocytes. Journal of Cell Science 98:225–232
    [Google Scholar]
37. Nicholson L. J., Hopwood P., Johannessen I., Salisbury J. R., Codd J., Thorley-Lawson D., Crawford D. H. 1997; Epstein–Barr virus latent membrane protein does not inhibit differentiation and induces tumorigenicity of human epithelial cells. Oncogene 15:275–283
    [Google Scholar]
38. Niederman J. C., Evans A. S., Subrahmanyan L., McCollum R. W. 1970; Prevalence, incidence and persistence of EB virus antibody in young adults. New England Journal of Medicine 282:361–365
    [Google Scholar]
39. Pattengale P. K., Smith R. W., Gerber P. 1973; Selective transformation of B lymphocytes by EB virus. Lancet ii:93–94
    [Google Scholar]
40. Pope J. H., Horne M. K., Scott W. 1968; Transformation of foetal human leucocytes in vitro by infiltrates of a human leukaemia cell line containing herpes-like virus. International Journal of Cancer 3:857–866
    [Google Scholar]
41. Rheinwald J. G., Beckett M. A. 1980; Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes. Cell 22:629–632
    [Google Scholar]
42. Rice R. H., Green H. 1979; Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions. Cell 18:681–694
    [Google Scholar]
43. Rickinson A. B., Kieff E. 1996; Epstein -Barr virus. In Fields Virology 3rd edn, pp 2397–2446 Edited by Fields B., Knipe D., Howley P. Philadelphia: Lippincott–Raven;
    [Google Scholar]
44. Sassone-Corsi P., Visvader J., Ferland L., Mellon P. L., Verma I. M. 1988; Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element. Genes & Development 2:1529–1538
    [Google Scholar]
45. Schwarz E., Freese U. K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., zur Hausen H. 1985; Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111–114
    [Google Scholar]
46. Schwarzmann F., Prang N., Reichelt B., Rinkes B., Haist S., Marschall M., Wolf H. 1994; Negatively cis-acting elements in the distal part of the promoter of Epstein–Barr virus trans-activator gene BZLF1. Journal of General Virology 75:1999–2006
    [Google Scholar]
47. Sheng M., Thompson M. A., Greenberg M. E. 1991; CREB: a Ca²⁺-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 252:1427–1430
    [Google Scholar]
48. Shimomura A., Ogawa Y., Kitani T., Fujisawa H., Hagiwara M. 1996; Calmodulin-dependent protein kinase II potentiates transcriptional activation through activating transcription factor 1 but not cAMP response element-binding protein. Journal of Biological Chemistry 271:17957–17960
    [Google Scholar]
49. Sixbey J. W. 1989; Epstein -Barr virus and epithelial cells. In Advances in Viral Oncology pp 187–202 Edited by Klein G. New York: Raven Press;
    [Google Scholar]
50. Sixbey J. W., Vesterinen E. H., Nedrud J. G., Raab-Traub N., Walton L. A., Pagano J. S. 1983; Replication of Epstein–Barr virus in human epithelial cells infected in vitro. Nature 306:480–483
    [Google Scholar]
51. Sixbey J. W., Nedrud J. G., Raab-Traub N., Hanes R. A., Pagano J. S. 1984; Epstein–Barr virus replication in oropharyngeal epithelial cells. New England Journal of Medicine 310:1225–1230
    [Google Scholar]
52. Sixbey J. W., Lemon S. M., Pagano J. S. 1986; A second site for Epstein–Barr virus shedding: the uterine cervix. Lancet ii:1122–1124
    [Google Scholar]
53. Sun P., Enslen H., Myung P. S., Maurer R. A. 1994; Differential activation of CREB by Ca²⁺/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity. Genes & Development 8:2527–2539
    [Google Scholar]
54. Takada K., Ono Y. 1989; Synchronous and sequential activation of latently infected Epstein–Barr virus genomes. Journal of Virology 63:445–449
    [Google Scholar]
55. Takada K., Shimizu N., Sakuma S., Ono Y. 1986; trans Activation of the latent Epstein–Barr virus (EBV) genome after transfection of the EBV DNA fragment. Journal of Virology 57:1016–1022
    [Google Scholar]
56. Tovey M. G., Lenoir G., Begon-Lours J. 1978; Activation of latent Epstein–Barr virus by antibody to human IgM. Nature 276:270–272
    [Google Scholar]
57. Urier G., Buisson M., Chambard P., Sergeant A. 1989; The Epstein–Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites. EMBO Journal 8:1447–1453
    [Google Scholar]
58. Wang Y. C. J., Huang J.-M., Montalvo E. A. 1997; Characterization of proteins binding to the ZII element in the Epstein–Barr virus BZLF1 promoter: transactivation by ATF1. Virology 227:323–330
    [Google Scholar]
59. Zur Hausen H., O’Neill F. J., Freese U. K., Hecker E. 1978; Persisting oncogenic herpesvirus induced by the tumour promoter TPA. Nature 272:373–375
    [Google Scholar]